Evotec SE (ETR:EVT)
6.19
+0.36 (6.18%)
At close: Feb 13, 2026
Evotec SE Market Cap
Evotec SE has a market cap or net worth of €1.1 billion as of February 13, 2026. Its market cap has decreased by -25.55% in one year.
Market Cap
1.10B
Enterprise Value
1.34B
Revenue
756.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.19
Market Cap Chart
Since November 11, 1999, Evotec SE's market cap has increased from 4.47M to 1.10B, an increase of 24,429.99%. That is a compound annual growth rate of 23.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.10B | 13.50% |
| Dec 30, 2025 | 966.41M | -33.49% |
| Dec 30, 2024 | 1.45B | -61.41% |
| Dec 29, 2023 | 3.77B | 39.63% |
| Dec 30, 2022 | 2.70B | -63.78% |
| Dec 30, 2021 | 7.44B | 50.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.56B |
| Siemens Healthineers AG | 45.39B |
| Bayer Aktiengesellschaft | 45.18B |
| Fresenius SE & Co. KGaA | 28.53B |
| Carl Zeiss Meditec AG | 2.35B |
| SCHOTT Pharma AG & Co. KGaA | 2.26B |
| Dermapharm Holding SE | 1.99B |
| Redcare Pharmacy NV | 1.40B |